221 related articles for article (PubMed ID: 24445756)
1. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram.
Sweldens C; Peeters S; van Limbergen E; Janssen H; Laenen A; Patil S; Van Zee KJ; Weltens C
Cancer J; 2014; 20(1):1-7. PubMed ID: 24445756
[TBL] [Abstract][Full Text] [Related]
2. Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast.
Wang F; Li H; Tan PH; Chua ET; Yeo RM; Lim FL; Kim SW; Tan DY; Wong FY
Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):684-91. PubMed ID: 25194727
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.
Yi M; Meric-Bernstam F; Kuerer HM; Mittendorf EA; Bedrosian I; Lucci A; Hwang RF; Crow JR; Luo S; Hunt KK
J Clin Oncol; 2012 Feb; 30(6):600-7. PubMed ID: 22253459
[TBL] [Abstract][Full Text] [Related]
4. Ipsilateral tumor recurrence risk in women with ductal carcinoma in situ: application of the Van Nuys Prognostic Index and the Memorial Sloan Kettering Cancer Center nomogram.
Hashiba KA; Bahl M
Breast Cancer Res Treat; 2023 Nov; 202(1):185-190. PubMed ID: 37518825
[TBL] [Abstract][Full Text] [Related]
5. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.
Collins LC; Achacoso N; Haque R; Nekhlyudov L; Quesenberry CP; Schnitt SJ; Habel LA; Fletcher SW
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S502-8. PubMed ID: 26059650
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery.
Kuo SH; Lo C; Chen YH; Lien HC; Kuo WH; Wang MY; Lee YH; Huang CS
Clin Breast Cancer; 2018 Dec; 18(6):441-450.e2. PubMed ID: 29709458
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Local Recurrence Risk in Ductal Carcinoma In Situ and External Validation of the Memorial Sloan Kettering Cancer Center Nomogram.
Oses G; Mension E; Pumarola C; Castillo H; Francesc L; Torras I; Cebrecos I; Caparrós X; Ganau S; Ubeda B; Bargallo X; González B; Sanfeliu E; Vidal-Sicart S; Moreno R; Muñoz M; Santamaría G; Mollà M
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190320
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Web-Based IBTR! 2.0 Nomogram to Predict for Ipsilateral Breast Tumor Recurrence After Breast-Conserving Therapy.
Kindts I; Laenen A; Peeters S; Janssen H; Depuydt T; Nevelsteen I; Van Limbergen E; Weltens C
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1477-1484. PubMed ID: 27315662
[TBL] [Abstract][Full Text] [Related]
9. External validation and modification of nomogram for predicting positive resection margins before breast conserving surgery.
Jung JJ; Kang E; Kim EK; Kim SM; Jang M; La Yun B; Park SY; Shin HC
Breast Cancer Res Treat; 2020 Sep; 183(2):373-380. PubMed ID: 32647937
[TBL] [Abstract][Full Text] [Related]
10. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Memorial Sloan-Kettering Cancer Center Nomogram to Predict Overall Survival After Curative Colectomy in a Chinese Colon Cancer Population.
Liu M; Qu H; Bu Z; Chen D; Jiang B; Cui M; Xing J; Yang H; Wang Z; Di J; Chen L; Zhang C; Yao Z; Zhang N; Tan F; Gu J; Li Z; Su X
Ann Surg Oncol; 2015 Nov; 22(12):3881-7. PubMed ID: 25963477
[TBL] [Abstract][Full Text] [Related]
12. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
[TBL] [Abstract][Full Text] [Related]
13. Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Vicini FA; Shaitelman S; Wilkinson JB; Shah C; Ye H; Kestin LL; Goldstein NS; Chen PY; Martinez AA
Breast J; 2013; 19(4):365-73. PubMed ID: 23815268
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.
Rudloff U; Jacks LM; Goldberg JI; Wynveen CA; Brogi E; Patil S; Van Zee KJ
J Clin Oncol; 2010 Aug; 28(23):3762-9. PubMed ID: 20625132
[TBL] [Abstract][Full Text] [Related]
16. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making.
Pleijhuis RG; Kwast AB; Jansen L; de Vries J; Lanting R; Bart J; Wiggers T; van Dam GM; Siesling S
Breast; 2013 Oct; 22(5):773-9. PubMed ID: 23462681
[TBL] [Abstract][Full Text] [Related]
17. Complementary role of the Memorial Sloan Kettering Cancer Center nomogram to the American Joint Committee on Cancer system for the prediction of relapse of major salivary gland carcinoma after surgery.
Chou WC; Chang KP; Lu CH; Chen MF; Cheng YF; Yeh KY; Wang CH; Lin YC; Yeh TS
Head Neck; 2017 May; 39(5):860-867. PubMed ID: 28152230
[TBL] [Abstract][Full Text] [Related]
18. Validation of a Novel Nomogram for Prediction of Local Relapse after Surgery for Invasive Breast Carcinoma.
Corso G; Maisonneuve P; Massari G; Invento A; Pravettoni G; De Scalzi A; Intra M; Galimberti V; Morigi C; Lauretta M; Sacchini V; Veronesi P
Ann Surg Oncol; 2020 Jun; 27(6):1864-1874. PubMed ID: 31965372
[TBL] [Abstract][Full Text] [Related]
19. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy.
Rudloff U; Brogi E; Brockway JP; Goldberg JI; Cranor M; Wynveen CA; Nehhozina T; Reiner AS; Patil S; Van Zee KJ
Cancer; 2009 Mar; 115(6):1203-14. PubMed ID: 19170233
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a breast cancer nomogram to predict ipsilateral breast relapse after breast-conserving therapy.
Kindts I; Laenen A; Peeters S; Janssen H; Depuydt T; Neven P; Van Limbergen E; Weltens C
Radiother Oncol; 2016 Apr; 119(1):45-51. PubMed ID: 26879286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
